Primis Financial Corp. (NASDAQ: FRST) has announced a signed non-binding term sheet to sell a portion of its shares in Panacea Financial Holdings, Inc. This move is expected to generate approximately $22 million in proceeds for Primis and an additional pre-tax gain of between $6.5 and $7.0 million, as the sales price per share surpasses the carrying value as of March 31, 2025. The sale follows the deconsolidation of Panacea Financial Holdings earlier this year. Primis CEO Dennis J. Zember, Jr. highlighted that the proceeds will enable the company to pursue strategies such as a share repurchase program and accelerated growth initiatives. Despite the sale, Primis remains committed to Panacea's long-term potential and its mission to provide tech-enabled financial solutions for doctors nationwide.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。